In Europe, biosimilar medicines have captured 7% more of the biologics market over a 5-year period

Market review Biosimilar medicines policy 2023 - Policy… 27 September 2023 The Biosimilar Market Access Committee (Biosimilar medicines Group, a Medicines…
IQVIA - Assessing the Biosimilar Void 30 October 2023 While biosimilar competition in Europe has played a vital role…
Ready in a crisis: Medicines for Europe commits at one year… 8 December 2022 Medicines for Europe members are major suppliers of medicines for…
EU pharmaceutical legislation reform critical to sustain… 6 October 2022 The EU plans to update its 20-year-old pharmaceutical legislation early…